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Abstract— Anacyclus valentinus L. is a common annual 
plant in Algeria, known for her various therapeutic 
effects. In addition, the plant is used as a food condiment. 
We reported our investigations on the chemical 
compositions and the antiarthritic activity of methanolic 
extract of A. valentinus (MEAV). The polyphenol 
extraction by maceration with methanol (80%) gave 
yields of 17.82%. The identification by LC-MS and 
colorimetric assays revealed the wealth of methanolic 
extracts on phenolic compounds including flavonoids 
(52.15 mg Equ/g) and lactones.  
Acute oral toxicity of extract was performed in line with 
OECD guidelines and the lethal dose 50 was assessed 
greater than 2500 mg/Kg. Regarding the anti-arthritic 
power, rheumatoid arthritis was induced by Freund's 
adjuvant in rats. The methanolic extract of A. valentinus 
presented a largest effect with weight gain, an arthritic 
score, thymus indices; spleen and serum parameters close 
to those of the control. The extract also inhibited edema 
and restored cartilage structure.  
Keywords— Anacyclus valentinus, Arthritis, diclofenac 
sodium, Freund's complete adjuvant, paw volume 
 
I. INTRODUCTION 
Rheumatoid arthritis (RA) is a chronic and systemic 
autoimmune joint disease characterized by pain, swelling 
and inflammation of peripheral joint and destruction of 
articular tissues and restricted joint movement [1]. RA is 
one of the most common inflammatory disorders affecting 
approximately 0.5–1.0% of global adult population [2]. 
The systemic ramifications of the disease, apart from 
morbidity and mortality, include cardiopathy, 
nephropathy, vasculopathy and pulmonary and cutaneous 
disorders [3]. 
Conventional medicines used for RA include 
non-steroidal anti-inflmmatory drugs (NSAIDs), 
disease-modifying anti-rheumatic drugs (DMARDs), 
biological response modifiers, and corticosteroids [4]. 
However, these treatments are accompanied by frequently 
toxicity and severe side effects. Therefore, more patients 
look for natural agents with relatively less side effects. 
Plant derived drugs serve as lead molecules to develop 
more effective and less toxic medicines [5].  
Anacyclus valentinus is a medicinal plant belonging to the 
family Asteraceae, locally known as «Guertoufa» [6] and 
mainly distributed in the Mediterranean basin and in 
northern Africa [7]. The plant is widely used in folk 
medicine for treatment of diverse diseases, such as 
diabetes [8] and cholesterol [9]. A. valentinus has an 
inhibitory effect on bacteria [10] and fungal [11]. It is also 
used in some parts of the country as a food condiment. 
Phytochemical studies on plants belonging to the genius 
Anacyclus made known the presence of terpenoids, 
steroids, coumarin and flavonoids like quercetin and 
luteolin [12].  Although the plant possesses many 
potential therapeutic activities in traditional system and 
containing rich phytochemical constituents, no work has 
been still done about the anti arthritic activity. Taking 
these facts into considerations the present study made an 
attempt to study the chemical composition and to evaluate 
the anti arthritic activity of methonolic extract of A. 
valentinus against Freund’s complete adjuvant induced 
arthritis in experimental rats. 
 
II.  METHODOLOGY  
2.1. Plant material 
The areal parts of Anacyclus valentinus were collected on 
October 2013, from local area of El- Bayadh, Algeria. 
The plant material was identified and authenticated by 
botanists from Department of Biology, University of 
Mascara, Algeria. The plant was shade dried powdered in 
grinder and passed through sieve of mesh size N°40.  
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2.2. Preparation of extract 
10 g of dried powder was macerated with 80% methanol 
at room temperature for 24h. The plant residue was re-
extracted with addition of 80% methanol, and filtered 
again after 24 h. Combined filtrates were concentrated by 
evaporation, dried in desiccator and were stored in airtight 
containers until usage [13]. 
 
2.3. Analysis of extract 
2.3.1. Total phenolic content determination (TPC) 
The total phenolic content of the extract was determined 
by the Folin - Ciocalteau method [14]. Briefly 200 μl of 
the extract was added to 1000 μl of Folin-Ciocalteau 
reagent (diluted to 10% in distilled water) and 800 μl of 
sodium carbonate at 7,5 %. The mixture was incubated at 
room temperature for 30 minutes. The absorbance was 
measured at 760 nm. Gallic acid in the concentration 
range of 0-170 µg/ml was used as standard for 
construction of calibration curve. The total phenolic 
content was expressed as mg/g in terms of gallic acid 
equivalents (GAE). 
 
2.3.2. Total flavonoid content determination (TFC) 
Aluminum chloride colorimetric method was used for 
estimation of total flvonoid content [15]. 500 μl of extract 
was mixed with 1500 μl of distilled water, methanol, 
150μl of sodium nitrite (6%). After 5min, 150 μl ml of 
aluminium chloride (10%) was incorporated and set aside 
at room temperature for 6 min. The absorbance of the 
reaction mixture was measured at 510 nm with ultraviolet 
(UV) visible spectrophotometer. The total flvonoid 
content was expressed in terms of mg/g in terms of 
quercetin equivalents (QE). 
 
2.3.3. LC/MS anlysis 
The identification of the phenolic compounds from A. 
valentinus was carried out using liquid phase 
chromatography coupled with mass spectrometry (LC-
MS). The methanolic extract was accurately weighed, and 
dissolved in methanol. 5.0 μL of sample was injected into 
Shimadzu LC/MS chromatography equipment. LC-MS 
analysis was performed on on a Phenomenex Luna 3u 
C18 column, whith UV detector. The mobile phase 
consisted of ultra-pure distilled water and acetonitrile. 
The solvent A consists of 50% water + 50% acetonitrile, 
while the solvent B is composed of 25% water + 75%. 
The flow rate was 0.4 mL/min. The column temperature 
was set at 40 ° C.   
 
2.4. Drugs and chemical reagent  
Diclofenac sodium was purchased from Pharmacy 
(Mascara, Algeria). Freund’s complete adjuvant agent 
(FCA) (Sigma Aldrich), CRP and FR kits (Spinreact) 
were obtained from was obtained from the university. 
 
2.5. Animals  
Healthy adult male albino rats of Wistar strain "Rattus 
norvegecus" (weighing 150 – 200 g) were used. The 
experimental procedures and protocols were carried out in 
accordance with ethical guidelines.  Animals were 
provided by the Experimental Station of the University of 
Mascara/Algeria. They were housed under standard 
conditions of temperature (24 ± 2 °C) with a 12:12 light: 
dark cycle and relative humidity (50 - 60 %). The animals 
were given standard diet and water ad libitum.  
 
2.6. Acute toxicity 
Acute oral toxicity study of methanolic extract of A. 
valentinus was performed in line with 
OECD guideline 423[16]. 
 
2.7. Induction of arthritis 
Adjuvant arthritis was induced as described by [17]. 
Briefly, animals were injected intra-plantar with 0.1 ml of 
Complete Freund’s Adjuvant (CFA) into the left hind paw 
of each rat. This consists of Mycobacterium butyricum 
suspended in heavy paraffin oil. Methanolic extract 
(300mg/Kg) and diclofénac sodium (20mg/Kg) were 
administered to rats in the various groups. For the 
comparison, two control groups were used arthritic and 
non-arthritic controls or vehicle control. 
 
2.8. Drug administration 
Two sets of experiments were performed. In the first set 
of experiments (preventive protocol), the effect of drugs 
was investigated when given 2h before induction of 
arthritis. The animals were grouped as fallow: Group I: 
arthritic control; Group II: non-arthritic control 
(Receiving 10 ml / Kg of sterile physiological water); 
Group III: treated with diclofenac sodium; Group IV: 
pre-treated with methanolic extract of A. valentinus 
(MEAV). 
In the second set of experiments, effect of the drugs on 
established arthritis (curative protocol) was studied. 
Drugs were administered on day 9 after the induction. 
The animals were randomly grouped as fallow: Group I, 
Group II and Group III are the same as for the previous 
test; Group IV”: treated with MEAV. 
 
2.9. Parameter assessment  
2.9.1. Paw swelling 
The pad thicknesses of the injected paw were measured 
before and every other day after FCA injection using a 
calliper. The paw swelling at each time point was 
expressed as an increase in the footpad thickness (mm) 
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[18]. For groups pre-treated, measurements were taken on 
the day of induction on the 5th, 10th and 15th day of 
treatment. While, for animals subjected to curative tests, 
the thickness of the paw was determined on the day of 
induction, on the 1st, the 7th and the 15th day of 
treatment. 
 
2.9.2. Arthritic index 
At the end of the experiments, morphological feature of 
arthritis was monitored, using the criteria as indicated in 
"TABLE 1" for each animal.  The scores for each paw 
were then added to get the total arthritic index. The 
average of treated animals is compared with the control 
group [19]. 
 
Table.1: Shows the scores of arthritic index 
Lesion 
site   
Nature of lesion  Score 
Ears   Absence of nodules and ridness 
Presence of nodules and ridness 
 
 
0 
1 
Nose  No swelling of connected tissue 
Intensive swelling of connected tissue  
 
 
0 
1 
 
Tail   
Absence of nodules 
Presence of nodules 
 
 
0 
1 
For 
paws 
Absence of inflammation 
Inflammation at least 1 joint 
 
 
0 
1 
 
Hind 
paws 
Absence of inflammation 
Slight inflammation  
Moderate inflammation  
Marked inflammation  
 
 
 
 
0 
1 
2 
3 
 
2.9.3. Measurement of body weight 
The body weight of rats was measured regularly using an 
analytical balance. The initial weight and final weight of 
each group were recorded. 
 
2.9.4. Thymus index and spleen index assay  
At the end of experiments, the animals were sacrificed 
and thymus and spleen were promptly removed and 
weighed. The indexes of thymus and spleen were 
expressed as the ratio of thymus and spleen wet weight 
versus body weight (mg/g), respectively [20]. 
 
2.9.5. Blood analysis 
Blood samples were collected; centrifuged and 
supernatant serum was collected. Different parameters 
were estimated like alkaline phosphatase marker for bone 
destruction (ALP) [21], rheumatoid factor and C-reactive 
protein marker of inflammation. These latter were 
measured by latex agglutination method. Values were 
expressed as IU/l, IU/ml and mg/L respectively. 
 
2.9.6. Radiographic analysis 
For radiological studies, the affected paws of 
experimental rats were removed and preserved in 10% 
formalin. X-ray images were taken for these paws, and 
checked for the soft swelling, bony erosions and 
narrowing of the spaces between joints [22]. 
 
2.10. Statistical analysis  
All the data are presented as mean ± SD. Statistical 
analysis was performed with ANOVA. P values below 
0.05 (p <0.05) were considered statistically significant.  
 
III. RESULTS 
3.1. Total phenolic content and flavonoid content 
Total phenolic and total flvonoid content of the 
methanolic extract is shown in table 2. Following the 
table, MEAV which gave a yield of 17.82 % is very rich 
in phenolic compounds, especially flavonoids which 
occupy 45.16% of the totality of the phenolic compounds. 
 
Table.2: Yield, total phenolic content and total flavonoid 
content of methanolic extract of A. valentinus 
Yield (%) TPC (mg GAE/g) TFC (mg 
QE/g) 
17.82 ± 0.49 115.47 ± 0.13 52.15 ± 0.78 
 
3.2. LC-MS analysis of MEAV 
The chemical composition of MEAV was further 
investigated by LC-MS analysis (Fig.1, Table 3). The 
table showed the richness of MEAV in flavonoids. Many 
compounds have characteristic spectra of flavonols 
(kaempferol, quercetin, myricetin), flavones (apigenin, 
luteolin) and flavanols (catechin). These results confirm 
the colorimetric analysis.The analysis also revealed the 
presence of derivatives of phenolic acids (sinapic acid, 
ferulic acid-β-glucoside), sesquiterpenes (lycoperodine) 
and derivatives of thymol (9,10-dihydroxy-8-methoxy 
thymol). 
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Fig.1: LC-MS-ESI spectrum in positive (up) and negative 
(low) form of MEAV 
 
Table.3: Identification of MEAV by LC-MS 
Pic 
N° 
m/z 
Ions +/ - 
Possible identification 
4 266,2 Apigenin  
1 /133,1 malic Acide 
2 /173,0 Ascorbique Acide  
3 /187,0 azelaïque Acide  
4 /189,1 Catechin 
5 /215,0 Lycoperodin 1 
6 /217,0 9,10-dihydroxy-8-methoxy thymol 
8 /225,1 sinapic Acide  
10 /355,1 β-glucosid ferulic Acide  
11 /371,1 Myricetin mono-acetate 
Di hydroxy-tetra methoxy flavone  
13 /431,1 Apigenine -7-O- glucoside 
Kaempferol -3-O- rhamnoside 
14 /447,0 Luteolin 3-O-β- glucopyranoside 
Quercetin 3-O- rhamnoside 
 
3.3. Acute oral toxicity 
There was neither change in behavioral pattern or any 
sign of toxicity during the observations up to 14 days. In 
addition, no mortality was recorded, the LD50 is therefore 
assumed to be greater than 2500 mg/Kg (the biological 
evaluation was carried out at doses between 200 and 2500 
mg/kg). We can conclude that MEAV is safe when 
administered orally.  
 
3.4. Effect of methanolic extract on adjuvant induced 
arthritis  
3.4.1. Paw swelling 
 
Fig.2: Effect of methanolic extract of A. valentinus 
(MEAV) on paw swelling 
 
Paw swelling is one of the major factors in evaluating the 
degree of inflammation and therapeutic efficacy of the 
drug. Rats injected with FCA (group II) showed a 
significant increase in paw volume when compared to the 
normal rats (group I). Pre-treatment with MEAV at the 
dose of 300 mg/kg inhibited the formation of edema. 
However, the curative treatment with extract and 
diclofenac showed a significant reduction in rat paw 
thickness when compared with the group II (Fig.2). 
 
3.4.2. Arthritic index 
As shown in figure 3, after FCA immunization, the rats 
showed a significant (P < 0.05) increase of arthritis index. 
However, pre-treatment and treatment with MEAV at 
300mg/Kg and diclofénac at 20 mg/kg significantly 
diminished the arthritis index compared with FCA group. 
Noting that, the lowest index was recorded in rats 
receiving MEAV as a preventive measure. 
 
 
Fig.3: Arthritis index in rats receiving diclofenac and 
MEAV 
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3.4.3. Measurement of body weight 
 
Fig.4: Mean changes in body weight 
 
The relationship between the extent of joint inflammation 
and the weight loss were investigated. As shown in figure 
4, the average body weights of the rats receiving normal 
saline (group I) was increased normally with a gain of 
13g. On the other hand, a massive and significant weight 
loss appears in arthritic rats. However, administration of 
different drugs significantly attenuated body weight loss. 
They are ranked in descending order as follows: PRE 
MEAV > CUR MEAV > Diclofenac.  
 
3.4.4. Thymus index and spleen index assay  
The index of thymus and spleen was assayed the day of 
sacrifice. Results report an increase in thymus and spleen 
index of FCA control group compared to normal control 
group. There was significantly (< 0.05) reduction of index 
of thymus and spleen in MEAV treatments groups (Table 
4). Diclofenac treatment also significantly decreased the 
spleen index and thymus index. 
However, the most important result was registered for 
MEAV preventive treatment compared with normal 
group. 
 
Table.4: Effect of MEAV on immune organs in arthritic 
rats 
 Thymus Index Spleen Index 
Vehicle 0.683 ± 0.101 2.320 ± 0.212 
FCA 1.295 ± 0.131 3.387 ± 0.151 
Diclofenac 0.839 ± 0.128 2.732 ± 0.237 
PRE MEAV 0.690 ± 0.177 2.478 ± 0.594 
CUR MEAV 0.741 ± 0.117 2.751 ± 0.278 
 
3.4.5. Blood analysis 
Table 5 depicts the effect of MEAV on levels of blood 
marker in arthritic rat serum. A significant increase in the 
levels of ALP, RF and CRP was observed in arthritic rats. 
The administration of MEAV (300mg/kg) and diclofenac 
(20mg/kg) significantly decreased all these parameters 
compared to FCA control (< 0.05). 
 
Table.5: Effect of MEAV on serum parameters in arthritic 
rats 
 ALP (UI/L) RF (UI/ml) CRP 
(mg/L) 
Vehicle 79.65 ± 3.90 8 ± 0 6 ± 0 
CFA 114.17 ± 
4.01 
57.60 ± 
14.31 
38.40 ± 
13.14 
Diclofenac 93.48 ± 8.10 14.40 ± 
10.43 
7.20 ± 2.68 
PRE MEAV 77.29 ± 8.44 9.60 ± 3.57 6 ± 0 
CUR MEAV 81.28 ± 6.24 11.20 ± 4.38 7.20 ± 2.68 
 
3.4.6. Radiographic analysis 
The radiographic images of the joints of all groups of rats 
are shown in Fig.5. The articulation of normal control 
group presented a normal opacity, joint space and 
cartilage appeared to be normal. 
As shown in this figure, it is evident from the 
radiographic images that adjuvant treated rats (group II) 
developed periosteal reaction, irregular joint space with 
opacity essentially concentrated at the level of the femoral 
condyle. The presence of knee arthritis (inflammation of 
the knee joint), joint instability and cartilage lysis were 
also observed. 
Although diclofenac treatment (group III) reduced 
inflammation and improved the metabolic function of 
rats, the radiographic image of joint showed opacity 
essentially concentrated at the tibial condyle. A lysis of 
the articular cartilage is also observed. 
In the extracts pre-treated group (group IV), the joint 
space appeared normal, no periosteal reaction was 
observed and joints appeared to be normal.Whereas, a 
slight bone lysis was determined at the joint of MEAV-
treated rats (group IV”). This joint had a radiographic 
appearance of normal opacity. 
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Group III 
 
Group IV 
 
Group IV” 
Fig.5: X-ray photographs of left hind paw of each group 
of rats 
 
IV. DISCUSSION 
Adjuvant-induced arthritis is commonly used in 
experimental model for preclinical studies. Due to its 
short duration of testing, easy measurement and 
similarities to human RA, this model has been used 
frequently to evaluate therapeutic agents.  In this model, 
rats developed a chronic swelling in multiple joints with 
influence of inflammatory cells, erosion of joint cartilage 
and bone destruction and remodelling [23].These 
inflammatory changes eventually result in the complete 
destruction of joint stability and mobility in the arthritic 
rats. Also, soft tissue swelling around the ankle joints was 
appeared during the progress of arthritis in FCA injected 
rats, which was considered as oedema of the exacting 
tissues. 
Paw swelling is a parameter of measuring the anti-
arthritic activity of various drugs. The visual arthritic 
index was used to evaluate the severity of arthritis. The 
determination of paw swelling and arthritic index is 
simple, sensitive, and quick procedure for evaluating and 
assessing the degree of inflammation, the therapeutic and 
curative effects of drugs [24]. In the present study, 
treatment with MEAV markedly reduced paw swelling 
and arthritic index induced by FCA compared with FCA 
group. We further confirmed its protective effect. In fact, 
the preventive treatment gave results close to those of the 
normal control group.  
 
Progression of disease status and response to anti-
inflammatory therapy are indirectly linked with change in 
body weight. RA is associated with weight loss, known as 
rheumatoid cachexia which leads to the decreased 
physical activity, muscle strength and decreased daily 
performance [25]. Decrease in body weight was attributed 
to reduced absorption of 14C- glucose and 14C-leucine in 
rat’s intestine [26]. In the present investigation, the FCA 
treated rats showed less body weight gain as compared 
with diclofénac, extract pre-treated and extract treated 
arthritic rats. Thus, body weight gain may be due to the 
restoration of the absorption capacity of the intestine. 
The spleen is a vital organ which serves as the available 
source of cells and antibody formation, known to be 
involved in immunological response in adjuvant 
arthritis.The RA model is an immune hyper-functional 
model, and marked splenomegaly, and lymphoid 
hyperplasia were associated with RA [27]. On the one 
hand, the increase in the weight of the spleen occurs 
following the release of the cytokines causing a 
perturbation of the histology of this organ. On the other 
hand, the variation in thymus weight is due to the 
suppression or imbalance of the immune system [28]. In 
the present study, it was found that MEAV significantly 
decreased the spleen index and thymus index induced by 
FCA compared with FCA group. This finding suggests 
that the extract may help in the recovery of the hyper-
functioning of immune organs without causing damage. 
Cytoplasmic cellular enzymes, such as alkaline 
phosphatase (ALP) are present in the body, but especially 
in the liver, bone, intestine, kidneys and white blood cells. 
The cellular localization of these enzymes assigns them a 
certain activity in the transfer of phosphoric esters 
through the membranes. They are involved in intestinal 
absorption and in the ossification process [29]. The 
attainment of the above-mentioned organs causes the 
liberation of ALP [30]. A significant (P < 0.05) reduction 
of ALP level was observed after administration of MEAV 
(300 mg/kg). 
Serum rheumatoid factor (RF) is the immunological 
expression of an individual's immune system reaction to 
the presence of an immunoglobulin molecule that is 
recognized as "non-self." This response results in the 
presence of immune complexes. These, in turn, bind 
complement and may eventually lead to synovium, 
cartilage, and bone destruction. Higher the levels of 
serum rheumatoid factor, higher are the development of 
inflammation [31]. A. valentinus pre-treated and treated 
animals showed significantly lesser serum RF when 
compared to disease control animals. 
CRP is an acute-phase protein and has been identified as 
an important biomarker for various inflammatory and 
degenerative diseases. The increment of this protein is 
due to a rise in the plasma concentration of IL-6, which is 
produced predominantly by macrophages [32]. Freund’s 
adjuvant induced arthritis rats increased the CRP level as 
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evidenced in the inflammatory process. A significant (P < 
0.05) reduction of CRP level was observed after 
administration of MEAV, suggested that decreased the 
inflammatory reactions. 
Radiographic changes in RA are useful indicative 
measures which specify the severity of the disease. Soft 
tissue swelling, bony erosions and narrowing of joint 
spaces can be observed [33]. The observed changes in 
radiographic findings can be attributed to positive benefits 
provided by the methanolic extract of A. valentinus on the 
inflammatory mechanisms in the joint tissues.  
It is well known that diclofenac had the anti-inflammatory 
and analgesic activity and often used to cure rheumatoid 
arthritis. However, this drug only inhibits primary 
response; do not affect the second response and immune 
function. In addition, it has obvious side effect and 
toxicity. Among all tests, the pre-treatment by MEAV 
proved to be the most effective in chronic inflammation 
when compared to the other groups. Its action is probably 
through the inhibition of the production of 
cyclooxygenase and prostaglandins. The extract, also has 
an immune-protective effect. In fact, several species of 
the Asteraceae family are known for their anti-
inflammatory effect [34, 35]. These could be attributed to 
the phenolic constituents present in the plant detected 
after phytochemical analysis.  
Quercetin, myricetin, kaempferol and apigenin identified 
in the extract have an effect on the synthesis of 
cyclooxygenase and lipoxygenase [36, 37]. Luteolin 3-O-
β-glucopyranoside also identified has an inhibitory effect 
on the synthesis of thromboxanes and consequently on the 
synthesis of the main arachidonic acid actor of the pro-
inflammatory process [38]. 
 
V. CONCLUSION 
The results obtained in the present study indicates that 
phenolic compounds of A. valentinus not only directs 
towards the control of arthritis progression and/or the 
inflammation associated with joint synovitis, but also 
prevents cartilage and bone destruction of the arthritic 
joints. Extracts of A. valentinus, may have great potential 
as an alternative to the therapeutic agents currently 
available for treatment of RA. However, there is need to 
isolate and characterize the active compounds responsible 
for the observed anti-arthritic activity. 
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